IM Therapeutics is Drug Discovery in United States that focus on platform screens business. Founded in 2015. They cover business area such as developer, drug molecule, specific blockade, an HLA protein, million, compound, optimal docking, rational drug design, bioassay, target therapeutic candidate, patient, access, HLA target, autoimmune disorder, celiac disease.
2015
( 9 years old in 2024 )
Platform Screens
-
299 Washington Street
Suite A
Woburn, MA 01801
United States
Private
developerdrug moleculespecific blockadean HLA proteinmillioncompoundoptimal dockingrational drug designbioassaytarget therapeutic candidatepatientaccessHLA targetautoimmune disorderceliac disease
* We use standard office opening hours in near IM Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
IM Therapeutics is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), IM Therapeutics business is focusing on Platform Screens.
IM Therapeutics headquarter office and corporate office address is located in 299 Washington Street Suite A Woburn, MA 01801 United States.
IM Therapeutics was founded in United States.
In 2024, IM Therapeutics is currently focus on platform screens sector.
Above is snippet of Google Trends for "platform screens" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with IM Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
